Publication | Open Access

The replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cells

Medicinal ChemistryDerivative (Chemistry)MedicineBreast Cancer CellsAnti-cancer AgentPharmacologyRadiation OncologyPhenol Group2-Ferrocenyl-1,1-diphenyl-but-l-ene CompoundsDrug Discovery